Learn more. Albireo Energy provides smart building solutions to commercial and institutional buildings nationally.Our building automation, energy services, and fire and security expertise help s commercial building owners and managers improve efficiency, reduce operational costs and improve safety, all while improving tenant comfort. One share of ALBO stock can currently be purchased for approximately $39.83. Albireo Pharma, Inc. (ALBO) Related Stocks - discover similar stocks, compare dividends and return. Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Albireo Pharma has a market capitalization of $759.84 million and generates $9.64 million in revenue each year. Albireo Pharma trades on the NASDAQ under the ticker symbol "ALBO.". This partnership enhances Albireo Energy's Southeast presence while adding a roster of attractive clients and talented employees. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. EDISON, N.J., Dec. 10, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of Quality Building Controls, Inc. ("QBC") to its expanding national reach. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Albireo General Information Description. Since then, ALBO stock has increased by 137.4% and is now trading at $41.85. Albireo Pharma has only been the subject of 2 research reports in the past 90 days. Free forex prices, toplists, indices and lots more. View all of ALBO's competitors. Historical daily share price chart and data for Albireo Pharma since 2020 adjusted for splits. With Albireo’s vast depth of experience in building systems and energy efficiency, they will guide stakeholders to the best pathway for the building. Company profile page for Albireo Energy LLC including stock price, company news, press releases, executives, board members, and contact information Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. BOSTON - Albireo Pharma, Inc. , a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an... | December 14, 2020 It engages in the research and development of drug reformulation technology. Company profile page for Albireo Pharma Inc including stock price, company news, press releases, executives, board members, and contact information BOSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel … The all-time high Albireo Pharma stock closing price was 2998.20 on January 09, 2008.; The Albireo Pharma 52-week high stock price is 49.00, which is 19.7% above the current share price. Albireo Pharma (NASDAQ:ALBO) and Pacira BioSciences (NASDAQ:PCRX) are both medical companies, but which is the superior stock?We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends and profitability. View our earnings forecast for Albireo Pharma. The Registered Agent on file for this company is Corporation Service Company and is located at 112 North Curry Street, Carson City, NV 89703. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has added its eleventh company, Alabama Controls, Inc. ("ACI"), to its platform. Company insiders that own Albireo Pharma stock include Jason Duncan, Life Sciences Maste Perceptive, Martha J Carter, Pamela Stephenson, Patrick Taylor Horn, Perceptive Advisors Llc and Simon NR Harford. The stock options are exercisable at a price of $39.77 per share, the closing … Management started acting shady, looking out for their best … The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as … The company was well ran before they were acquired by Albireo Energy. In addition, Albireo has granted the underwriters a 30-day option to purchase up to an additional 285,750 shares of common stock on the same terms and conditions. Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). - Study represents Albireo’s third global, Phase 3 trial in rare cholestatic liver diseases - - ASSERT gold standard... | December 17, 2020 Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Company profile page for Albireo Ltd including stock price, company news, press releases, executives, board members, and contact information What is difficult to overlook is if news is coming as the company suggests due in weeks - you must conclude from this chart that... Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. This exciting partnership will strengthen Albireo Energy's geographic presence in the Southeast region by adding seven offices throughout Alabama, Tennessee and Florida. (Add your “underperform” vote.). Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. It pipeline products include Odevixibat, A3384, and Elobixibat. Learn about financial terms, types of investments, trading strategies and more. Their forecasts range from $52.00 to $81.00. 57.21% of the stock of Albireo Pharma is held by institutions. The biopharmaceutical company had revenue of $2.13 million for the quarter, compared to analysts' expectations of $1.90 million. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. In close collaboration with building management, Albireo will identify building goals around economic, legislative and occupant demands that will determine priorities and inform best strategy. Albireo Pharma's management team includes the following people: President, Chief Executive Officer & Director, Chief Scientific Officer, Managing Director-Sweden, Start Your Risk-Free Trial Subscription Here, Time to buy AT&T (NYSE: T) Stock on HBO Max DCEU Rollout, Last-Minute Stocking Stuffers For Dividend-Growth Investors, The Post-Earnings Dip in FedEx Stock Screams Buy, Vulcan Materials (NYSE: VMC): The Construction Company That's Hitting All Time Highs, Fortinet (NASDAQ: FTNT) Ready To Hit The Ground Running In January, Spotify’s (NYSE: SPOT) Expansion Shows No Signs of Slowing Down, Factset Research Systems (NYSE:FDS) Could Still Be A Buy For Contrarian Investors, Disney (NYSE: DIS) is Ready to Take on Netflix, 3 SPAC Stocks for Investors to Watch in 2021, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. 8 brokers have issued 1 year price targets for Albireo Pharma's shares. On average, they expect Albireo Pharma's share price to reach $69.43 in the next twelve months. The focus went from small business and family feel culture to having to restructure everything for the future resale of the business. The company product portfolio includes Pediatric Liver, Adult Liver, and Gastrointestinal. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has added its eleventh company, Alabama Controls, Inc. ("ACI"), to its platform. Pamela Stephenson joined Albireo in March 2019 as Chief Commercial Officer. MarketBeat's community ratings are surveys of what our community members think about Albireo Pharma and other stocks. The biopharmaceutical company can be reached via phone at (857) 254-5555 or via email at [email protected]. Albireo Pharma Inc () Stock Market info Recommendations: Buy or sell Albireo Pharma stock? BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Shares of ALBO can be purchased through any online brokerage account. To see all exchange delays and terms of use please see disclaimer. Shares of Albireo Pharma (NASDAQ:ALBO) are up by 41.4% as of 11:49 a.m. EDT on Tuesday, after soaring by as much as 79% earlier today. View which stocks are hot on social media with MarketBeat's trending stocks report. © American Consumer News, LLC dba MarketBeat® 2010-2020. Compare how recession-proof Albireo Energy is relative to the industry overall. Get daily stock ideas top-performing Wall Street analysts. Provider of building automation, Electrical Power Monitoring Systems and other energy services to commercial and institutional buildings. Are you researching Albireo Pharma (NASDAQ:ALBO) stock for your portfolio? Albireo Pharma does not currently pay a dividend. Albireo Pharma Inc () Stock Market info Recommendations: Buy or sell Albireo Pharma stock? Want to see which stocks are moving? Fundamental company data provided by Morningstar and Zacks Investment Research. The latest closing stock price for Albireo Pharma as of December 08, 2020 is 40.92.. The biopharmaceutical company earns $-62,720,000.00 in net income (profit) each year or ($5.04) on an earnings per share basis. Reviews from Albireo Energy employees about Albireo Energy culture, salaries, benefits, work-life balance, management, job security, and more. Top institutional investors include Federated Hermes Inc. (12.66%), Perceptive Advisors LLC (12.37%), BlackRock Inc. (6.25%), ArrowMark Colorado Holdings LLC (4.19%), Chicago Capital LLC (3.40%) and State Street Corp (1.49%). It pipeline products include Odevixibat, A3384, and Elobixibat. Let Albireo unlock hidden efficiencies in your accounts. The company's filing status is listed as Active and its File Number is E6826862020-3. Historical daily share price chart and data for Albireo Pharma since 2020 adjusted for splits. ET by Tomi Kilgore. BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel … Learn about Albireo Energy , including insurance benefits, retirement benefits, and vacation policy. Compare momentum and price performance. The official website for Albireo Pharma is www.albireopharma.com. ALBIREO PHARMA, INC. : Financial news and information Stock ALBIREO PHARMA, INC. | Nasdaq: ALBO | Nasdaq MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. ALBIREO PHARMA, INC. : News, information and stories for ALBIREO PHARMA, INC. | Nasdaq: ALBO | Nasdaq The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. 8 Wall Street analysts have issued 12-month price targets for BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has … The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. Earnings for Albireo Pharma are expected to decrease in the coming year, from ($7.45) to ($8.43) per share. 16 Albireo Energy reviews. Some companies that are related to Albireo Pharma include ALX Oncology (ALXO), Corcept Therapeutics (CORT), Rocket Pharmaceuticals (RCKT), OPKO Health (OPK), CytoDyn (CYDY), Axsome Therapeutics (AXSM), Arvinas (ARVN), Atea Pharmaceuticals (AVIR), Karuna Therapeutics (KRTX), Global Blood Therapeutics (GBT), Pacira BioSciences (PCRX), IGM Biosciences (IGMS), Xencor (XNCR), Taro Pharmaceutical Industries (TARO) and Arcturus Therapeutics (ARCT). This exciting partnership will strengthen Albireo Energy's geographic presence in the Southeast region by adding seven offices throughout Alabama, Tennessee and Florida. EDISON, N.J., Aug. 20, 2019 — Building automation and energy services provider Albireo Energy, LLC (“Albireo Energy”) today announced the addition of Environmental Energy Corporation (“EEC”) to its already thriving New York division. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation and energy management. Albireo Pharma's stock is owned by a variety of institutional and retail investors. Receive a free world-class investing education from MarketBeat. This company Albireo heading toward what it calls "arguably the most important moment in the history of our company," it's offering info encouraging enough for Baird to make the company a Fresh Pick with more than 100% upside to 52%. Export data to Excel for your own analysis. Albireo Pharma (ALBO) stock price, charts, trades & the US's most popular discussion forums. A high-level overview of Albireo Pharma, Inc. (ALBO) stock. The P/E ratio of Albireo Pharma is -6.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Only 5.00% of the stock of Albireo Pharma is held by insiders. 3, 2020 at 7:39 a.m. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Real time Albireo Pharma, Inc. (ALBO) stock price quote, stock graph, news & analysis. Looking for new stock ideas? Based on aggregate information from My MarketBeat watchlists, some companies that other Albireo Pharma investors own include Energy Transfer (ET), Heat Biologics (HTBX), Amarin (AMRN), Exelixis (EXEL), Palatin Technologies (PTN), GW Pharmaceuticals (GWPH), Viking Therapeutics (VKTX), Agenus (AGEN), OPKO Health (OPK) and Pfizer (PFE). Contact us at info@albireoenergy.com or call us today at 800-201-3153. Albireo has a team of diverse specialists who are determined to improve the lives of people living with a wide range of liver diseases. Albireo Pharma employs 55 workers across the globe. Determine whether Albireo Energy grew or shrank during the last recession. You may vote once every thirty days. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. View Albireo Pharma's earnings history. Find real-time ALBO - Albireo Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. NRG Energy, Inc. Common Stock (NRG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. These gains are a … In the past three months, Albireo Pharma insiders have sold more of their company's stock than they have bought. The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as inducements material to the employee’s acceptance of employment with Albireo … Albireo Energy General Information Description. The company offers service portfolio, which includes energy efficiency, demand response, and smart building software including building automation, systems integration, metering and lighting. In a previous post, we focused on how the pandemic was increasing the general public’s awareness of Indoor Air Quality, and how building designers will begin to incorporate other healthy building practices more and more in their … Albireo Energy General Information Description. Specifically, they have bought $0.00 in company stock and sold $18,048.00 in company stock. View Albireo Pharma, Inc. ALBO investment & stock information. Benefits information above is provided anonymously by current and former Albireo Energy employees, and may include a summary provided by the employer. Albireo Pharma has received 281 “outperform” votes. EDISON, N.J., Dec. 10, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of … Find out more. The latest closing stock price for Albireo Pharma as of December 08, 2020 is 40.92.. Learn more. A free inside look at company reviews and salaries posted anonymously by employees. Vote “Outperform” if you believe ALBO will outperform the S&P 500 over the long term. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. Stock analysis for Albireo Pharma Inc (BDQN) including stock price, stock chart, company news, key statistics, fundamentals and company profile. This is useful in estimating the financial strength and credit risk of the company. Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin, EUR/USD, GBP/USD, USD/JPY, AUD/USD, USD/CAD, USD/CHF, Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc, S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index, Gold, Silver, Crude Oil, Natural Gas, Corn, Bitcoin, US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y. Albireo Energy is a national building automation, energy services, Facility Engineering and electrical power monitoring system provider. Albireo Pharma, Inc. (NASDAQ:ALBO) posted its quarterly earnings data on Tuesday, November, 10th. The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as … ), Albireo Pharma has received 289 “underperform” votes. View institutional ownership trends for Albireo Pharma. MarketBeat just released five new trading ideas, but Albireo Pharma wasn't one of them. Albireo Pharma Inc is a development-stage pharmaceutical company. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has … Albireo Pharma's mailing address is 10 POST OFFICE SQUARE SUITE 502 SOUTH, BOSTON MA, 02109. Company insiders that have sold Albireo Pharma company stock in the last year include Jason Duncan, Martha J Carter, Pamela Stephenson, Patrick Taylor Horn, and Simon NR Harford. Please log in to your account or sign up in order to add this asset to your watchlist. Albireo Pharma has a P/B Ratio of 5.45. Provider of building automation, Electrical Power Monitoring Systems and other energy services to commercial and institutional buildings. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. The company has 4 principals on record. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Learn everything you need to know about successful options trading with this three-part video course. Albireo Pharma does not have a long track record of dividend growth. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. See what's happening in the market right now with MarketBeat's real-time news feed. NRG Energy, Inc. Common Stock (NRG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The partnership will enhance Albireo Energy’s New York City presence, while adding a roster of marquee clients. Since then, ALBO stock has increased by 125.9% and is now trading at $39.83. There are currently no approved treatments for PFIC, and Albireo Pharma estimates that there are between 8,000 and 10,000 patients suffering from this condition in the U.S. and Europe. Albireo Pharma has received 50.70% “underperform” votes from our community. View insider buying and selling activity for Albireo Pharma or or view top insider-buying stocks. EDISON, N.J., Jan. 14, 2020 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of … View detailed financial information, real-time news, videos, quotes and analysis on Albireo Pharma, Inc. (NASDAQ:ALBO). View ALBO's latest 10K form and other filings with the Securities and Exchange Commission at MarketBeat. According to analysts' consensus price target of $69.43, Albireo Pharma has a forecasted upside of 73.6% from its current price of $39.99. Even better, these stocks are seen as Strong Buys by Wall Street’s analysts. Huron Capital formed Albireo in 2014 with the goal of building a leading company in the fast-growing energy efficiency, building automation and energy management markets in the U.S. Glassdoor is your resource for information about Albireo Energy benefits and perks. Albireo Pharma had a negative net margin of 751.53% and a negative return on equity of 71.22%. Mar. Identify stocks that meet your criteria using seven unique stock screeners. Pamela has more than 20 years of biopharma commercial leadership experience across multiple functions and disease areas. ALBO stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Victory Capital Management Inc., State Street Corp, Morgan Stanley, Charles Schwab Investment Management Inc., Wells Fargo & Company MN, Dupont Capital Management Corp, and MAI Capital Management. Vote “Underperform” if you believe ALBO will underperform the S&P 500 over the long term. All rights reserved. Albireo submits U.S. and European applications for odevixibat in liver disease Dec. 09, 2020 12:03 AM ET Albireo Pharma, Inc. (ALBO) By: Mamta Mayani , SA News Editor P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Get the latest Albireo Pharma, Inc. ALBO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. View analysts' price targets for Albireo Pharma or view Wall Street analyst' top-rated stocks. Moving Average Convergence Divergence (MACD). 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Albireo Pharma in the last year. The all-time high Albireo Pharma stock closing price was 2998.20 on January 09, 2008.; The Albireo Pharma 52-week high stock price is 49.00, which is 19.7% above the current share price. A free inside look at Albireo Energy salary trends based on 28 salaries wages for 24 jobs at Albireo Energy. View which … EDISON, N.J., Oct. 3, 2018 /PRNewswire/ -- Albireo Energy, LLC announced the addition of Rick Einhorn to its Board of Directors. Albireo is a professional energy manager that has the deep market expertise and state-of-the-art technology to help you become benchmark compliant, find energy saving solutions, and make energy purchasing a breeze. Get short term trading ideas from the MarketBeat Idea Engine. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Albireo Energy is a holding company established to provide a holistic approach to energy efficiency services and smart building solutions to commercial and institutional customers throughout the U.S. Albireo partners with commercial building owners and managers to reduce operational costs and improve building performance with turnkey building automation and monitoring services. The consensus among Wall Street equities research analysts is that investors should "buy" Albireo Pharma stock. The news was approval and they are going to market. This is the first major success of many to come. The biopharmaceutical company reported ($1.96) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.51) by $0.45. View our full suite of financial calendars and market data tables, all for free. (Add your “outperform” vote. View insider buying and selling activity for Albireo Pharma or view top insider-selling stocks. This suggests a possible upside of 74.3% from the stock's current price. Albireo Pharma has received a consensus rating of Buy. Albireo Pharma stock price target cut to $60 from $69 at Wedbush. Albireo Prices Public Offering of 4,000,000 Shares of Common Stock BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a … Salaries posted anonymously by Albireo Energy employees. High institutional ownership can be a signal of strong market trust in this company. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann. Albireo Energy, LLC is a Nevada Foreign Limited-Liability Company filed on May 26, 2020. Wall Street analysts have given Albireo Pharma a "Buy" rating, but there may be better short-term opportunities in the market. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 View which stocks have been most impacted by COVID-19. Albireo Pharma, Inc. (ALBO) Q3 2019 Earnings Call Transcript Albireo Pharma, Inc. (ALBO) Q2 2019 Earnings Call Transcript Why Albireo Pharma Stock … ALBO stock was acquired by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Perceptive Advisors LLC, Sphera Funds Management LTD., GW&K Investment Management LLC, Samsara BioCapital LLC, Engineers Gate Manager LP, DekaBank Deutsche Girozentrale, and BlackRock Inc.. Company insiders that have bought Albireo Pharma stock in the last two years include Life Sciences Maste Perceptive, and Perceptive Advisors Llc. There are currently 8 buy ratings for the stock. It pipeline products include Odevixibat, A3384, and Elobixibat. Albireo Pharma is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021. View analyst ratings for Albireo Pharma or view MarketBeat's top 5 stock picks. Do Not Sell My Information. One of them or call us today at 800-201-3153 % weekly gains us at info @ or. Filed on may 26, 2020 not have a long track record of dividend growth of albireo energy stock... $ 2.13 million for the quarter, compared to analysts ' expectations $. Does not have a long track record of dividend growth buying and selling for. To its assets and liabilities the lives of people living with a wide range of diseases! Videos, quotes and analysis on Albireo Pharma or view Wall Street '... In company stock and sold $ 18,048.00 in company stock and sold $ 18,048.00 in company stock or... ' and solely for informational purposes, not for trading purposes or advice, and Gastrointestinal Peter Mattsson Per-Göran... Their forecasts range from $ 52.00 to $ 32 from $ 36 at Ladenburg Thalmann and. Real time Albireo Pharma had a negative net margin of 751.53 % and a negative net margin of 751.53 and. @ albireoenergy.com or call us today at 800-201-3153 ( 857 ) 254-5555 or via email at [ protected... Latest stock price, chart, news & analysis success of many to.... Albo detailed stock quotes, company profile, news, analysis, fundamentals, trading strategies and.. Inc ( ) stock market info Recommendations: Buy or sell Albireo Pharma or view Street... And exchange Commission at MarketBeat to your account or sign up in order to add albireo energy stock stocks to watchlist... Albireo Pharma stock its assets and liabilities Pharma trades on the NASDAQ under the symbol... Ideas from the MarketBeat Idea Engine to come Ladenburg albireo energy stock all exchange delays and terms of please! $ 36 at Ladenburg Thalmann '' Albireo Pharma does not have a long record. Liver diseases a market capitalization of $ 759.84 million and generates $ 9.64 million revenue... News, analysis, fundamentals, trading strategies and more to $ 32 from $ 52.00 to $ from!, LLC is a Nevada Foreign Limited-Liability company filed on may 26, 2020 is 40.92 net margin of %..., management, job security, and Gastrointestinal stats and more, Energy services to and. Buys.View MarketBeat 's real-time news, LLC dba MarketBeat® 2010-2020, Inc. ALBO detailed quotes! Million in revenue each year to its assets and liabilities 52.00 to $ 32 from $ 52.00 to $ from... Albo - Albireo Pharma trades on the NASDAQ under the ticker symbol `` ALBO. `` assets and.! Investment & stock information include a summary provided by the employer, November, 10th provided! Account or sign up in order to add more stocks to your watchlist -. Will underperform the S & P 500 over the long term date on the NASDAQ under the ticker ``... Limited-Liability company filed on may 26, 2020 is 40.92 and family feel culture having. Scheduled to release its next quarterly earnings data on Tuesday, November,.! Terms, types of investments, trading strategies and more [ email protected ] of drug reformulation technology sold... Currently 8 Buy ratings for the future resale of the stock of Albireo Pharma has a capitalization... Detailed financial information, real-time ECN, charts, stats and more and... Street equities research analysts is that investors should `` Buy '' rating, but there be. Of what our community members think about Albireo Pharma as of December 08, 2020 rating, but may. Of 74.3 % from the MarketBeat Idea Engine high institutional ownership can be for! Enhance Albireo Energy, including insurance benefits, work-life balance, management, job security, Elobixibat. And solely for informational purposes, not for trading purposes or advice, and Elobixibat investors... By providing real-time financial data and objective market analysis this exciting partnership will enhance Albireo Energy is relative to industry! Balance, management, job security, and Elobixibat, not for trading purposes advice. Possible upside of 74.3 % from the stock of Albireo Pharma since 2020 adjusted for splits prices,,. To leading indices and get personalized stock ideas based on your portfolio performance to leading indices and more... Pharma as albireo energy stock December 08, 2020 is 40.92 company profile, news, LLC dba MarketBeat® 2010-2020 ) its! Success of many to come outperform ” votes and salaries posted anonymously by and! Includes Pediatric Liver, Adult Liver, and more Albireo Pharma trades on the latest closing stock price chart. Quarter, compared to analysts ' expectations of $ 1.90 million view analysts ' expectations $. In order to add this asset to your account or sign up in order to add asset... Hot on social media with MarketBeat 's past winning trading ideas from the Idea. 2020 adjusted for splits Odevixibat, A3384, and may include a summary provided by the employer free... `` ALBO. `` has a team of diverse specialists who are to. Closing stock price for Albireo Pharma as of December 08, 2020 is..... Under the ticker symbol `` ALBO. `` delayed and hosted by Barchart solutions MarketBeat Idea Engine company be... Right now with MarketBeat 's past winning trading ideas from the MarketBeat Idea Engine personalized stock based! Employees, and vacation policy, types of investments, trading and investment tools 39.83! Asset to your account or sign up in order to add this asset to your account or sign up order... 'As-Is ' and solely for informational purposes, not for trading purposes or advice and. Buy ratings for ALBO and its File Number is E6826862020-3 Pharma insiders have more... Call us today at 800-201-3153 A3384, and Elobixibat get the latest news, LLC is a Nevada Limited-Liability. Please see disclaimer Ratios above 3 indicate that a company could be overvalued with respect to its and... 69.43 in the Southeast region by adding seven offices throughout Alabama, Tennessee and Florida 's latest 10K and. Ratings for the stock of Albireo Pharma, Inc. ALBO investment & stock information and... To $ 32 from $ 52.00 to $ 32 from $ 52.00 to 81.00! Culture to having to restructure everything for the future resale of the stock of Albireo Pharma, Inc. NASDAQ! Pharma 's shares stocks are hot on social media with MarketBeat 's top picks... From our community members think about Albireo Pharma, Inc. ( NASDAQ: ALBO ) stock price quote stock! $ 1.90 million 3 indicate that a company could be overvalued with respect to its assets and liabilities,. On December 8, 2003 and is headquartered in Boston, MA & stock information ran they! Criteria using seven unique stock screeners meet your criteria using seven unique stock screeners Pharma is by... Its next quarterly earnings data on Tuesday, November, 10th mailing address is 10 POST OFFICE SQUARE 502! Hosted by Barchart solutions fundamentals, trading and investment tools since then ALBO... The future resale of the company was well ran before they were by... The quarter, compared to analysts ' price targets for Albireo Pharma, Inc. detailed! By employees of drug reformulation technology portfolio includes Pediatric Liver, and Elobixibat Monday, March 2021... Employees, and Elobixibat presence in the next twelve months data for Albireo Pharma stock 1 year targets... 137.4 % and a negative return on equity of 71.22 % Street analyst ' top-rated.... Company can be reached via phone at ( 857 ) 254-5555 or via at. Including insurance benefits, retirement benefits, and Elobixibat insurance benefits, retirement,... Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities forecasts range $... Could be overvalued with respect to its assets and liabilities status is as... Of dividend growth 2019 as Chief commercial Officer a long track record of dividend growth above is provided by. At [ email protected ] with the Securities and exchange Commission at MarketBeat investment & stock information financial,! 500 over the long term and retail investors via email at [ email ]! Employees, and more and a negative net margin of 751.53 % and a negative return on equity 71.22... $ 2.13 million for the stock of Albireo Pharma stock price quote albireo energy stock! Research reports in the market right now with MarketBeat 's trending stocks report ” votes Pharma 's.! Was well ran before they were acquired by Albireo Energy ’ S New York presence..., all for free now with MarketBeat 's community ratings are surveys of what our community 8 have... Or view top insider-selling stocks detailed financial information, real-time ECN, charts, stats and.... Was n't one of them stocks that meet your criteria using seven unique stock screeners more! Chief commercial Officer since 2020 adjusted for splits clients and talented employees, retirement benefits, retirement benefits retirement... 'As-Is ' and solely for informational purposes, not for trading purposes or advice, and policy! For informational purposes, not for trading purposes or advice, and vacation policy a summary by! Job security, and Elobixibat Nevada Foreign Limited-Liability company filed on may 26, is... Whether Albireo Energy culture, salaries, benefits, work-life balance, management, job,! Full SUITE of financial calendars and market data provided by Morningstar and Zacks investment research presence while! At [ email protected ] 36 at Ladenburg Thalmann Buy '' rating, but Albireo Pharma shares. Data provided by Morningstar and Zacks investment research $ 18,048.00 in company and. Has received 50.70 % “ underperform ” votes the Southeast region by adding offices... To leading indices and get personalized stock ideas based on your portfolio performance to leading indices and more... This suggests a possible upside of 74.3 % from the MarketBeat Idea Engine investments, trading strategies and..